---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-25-000206"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2025-10-21T23:59:59+00:00"
generated_at: "2026-05-17T02:56:14.134485+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Intuitive Surgical Q3 revenue $2.51B (+23% YoY); EPS $1.95 GAAP / $2.40 non-GAAP; procedures +20%

## Summary
- Worldwide procedures grew ~20% YoY; da Vinci +19%, Ion +52%.
- Revenue $2.51B (+23% YoY); GAAP net income $704M ($1.95/diluted share), non-GAAP $867M ($2.40).
- Placed 427 da Vinci systems (240 da Vinci 5); installed base 10,763 (+13% YoY). Ion base 954 (+30%).
- Repurchased 4.0M shares for $1.92B in Q3.
- FY2025 guidance: procedure growth ~17-17.5%; non-GAAP gross margin 67-67.5% (incl. tariff impact ~0.7% of revenue).

## SEC filing metadata
- accession: 0001035267-25-000206
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2025-10-21T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000206/0001035267-25-000206-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000206/isrg-20251021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-25-000206
- JSON: https://secwatch.observer/filing/0001035267-25-000206.json
- Plain text: https://secwatch.observer/filing/0001035267-25-000206.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.